共 12 条
- [1] Comparison of the Pharmacokinetics of Highly Variable Drugs in Healthy Subjects Using a Partial Replicated Crossover Study: A Fixed-Dose Combination of Fimasartan 120 mg and Atorvastatin 40 mg versus Separate Tablets [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 1953 - 1961
- [3] Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations [J]. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1999, 21 (09): : 625 - 628
- [4] Pharmacokinetics and Bioequivalence of Fixed-Dose Combination of Simvastatin and Ezetimibe Tablets: A Randomized, Crossover, Open-Label Study in Healthy Volunteers [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (08): : 938 - 946
- [5] Comparative Pharmacokinetics Between a Fixed-Dose Combination of Pitavastatin/Valsartan 4/160 mg and the Corresponding Individual Components Through a Partial Replicated Crossover Design in Healthy Male Subjects [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (05): : 615 - 622
- [6] Comparison of the Bioavailability and Tolerability of Fixed-Dose Combination Glimepiride/Metformin 2/500-mg Tablets Versus Separate Tablets: A Single-Dose, Randomized-Sequence, Open-Label, Two-Period Crossover Study in Healthy Korean Volunteers [J]. CLINICAL THERAPEUTICS, 2010, 32 (07) : 1408 - 1418
- [8] A randomized, open-label, single- dose, two-way crossover study to assess the pharmacokinetics between two tablets of fixed-dose combination formulation with raloxifene and cholecalciferol and concomitant administration of each agents in healthy male volunteers [J]. TRANSLATIONAL AND CLINICAL PHARMACOLOGY, 2022, 30 (03) : 136 - 144
- [9] Pharmacokinetics of a Fixed-Dose Combination of Atorvastatin and Metformin Extended Release versus Concurrent Administration of Individual FormulationsA Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover, Bioequivalence Study [J]. Clinical Drug Investigation, 2011, 31 : 853 - 863
- [10] Pharmacokinetics of a Fixed-Dose Combination of Atorvastatin and Metformin Extended Release versus Concurrent Administration of Individual Formulations A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover, Bioequivalence Study [J]. CLINICAL DRUG INVESTIGATION, 2011, 31 (12) : 853 - 863